Researchers say they’ve developed the world’s first reliable blood test for myalgic encephalomyelitis, or chronic fatigue syndrome (ME/CFS).
The test, created by scientists at the University of East Anglia and Oxford Biodynamics, identifies unique DNA-folding patterns linked to the condition.
In trials with 47 ME/CFS patients and 61 healthy people, the test showed 92% sensitivity and 98% specificity.
Lead researcher Prof Dmitry Pshezhetskiy said it could “transform how we diagnose and manage this complex disease.”
Currently, ME/CFS is diagnosed only through symptoms, often leading to years of misdiagnosis or dismissal.
Experts welcomed the breakthrough but urged caution. “The claims are premature,” warned Prof Chris Ponting of the University of Edinburgh.
Dr Charles Shepherd of the ME Association said more studies are needed to confirm the test’s accuracy across different stages and similar illnesses.
If validated, the test could cost around £1,000 and offer long-awaited hope for millions living with the misunderstood condition.
